Arranon 250 MG per 50 ML Injection
- RxCUI
- 616366
- RxNorm name
- Arranon 250 MG per 50 ML Injection
- Display name
- Arranon 250 MG per 50 ML Injection
- Full name
- Arranon 250 MG per 50 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:30
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arranon | NELARABINE | Sandoz Inc | 0f9051de-5c4d-4c0f-8c19-e15214498cca | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 616366 |
| Arranon | NELARABINE | Novartis Pharmaceuticals Corporation | fffa5d75-0dba-4ad7-a252-5f60fa28489a | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | 616366 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fffa5d75-0dba-4ad7-a252-5f60fa28489a | Arranon 250 MG per 50 ML Injection | SY | 10 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| fffa5d75-0dba-4ad7-a252-5f60fa28489a | 50 ML nelarabine 5 MG/ML Injection [Arranon] | SBD | 10 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| fffa5d75-0dba-4ad7-a252-5f60fa28489a | ARRANON 250 MG in 50 ML Injection | PSN | 10 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| 0f9051de-5c4d-4c0f-8c19-e15214498cca | 50 ML nelarabine 5 MG/ML Injection [Arranon] | SBD | 4 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| 0f9051de-5c4d-4c0f-8c19-e15214498cca | ARRANON 250 MG in 50 ML Injection | PSN | 4 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |
| 0f9051de-5c4d-4c0f-8c19-e15214498cca | Arranon 250 MG per 50 ML Injection | SY | 4 | These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON ® (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005 | 20250331 |